NCT06125769 2026-03-16
LITALHICA
Azienda Sanitaria Ospedaliera
Phase NA Recruiting
Clinical Trials
47 trialsNCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
NCT06178588 2026-02-24
Sacituzumab Govitecan for the Treatment for Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma
University of Kansas Medical Center
Phase 2 Active not recruiting
NCT05430698 2026-02-09
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Recruiting
NCT06739252 2026-01-28
Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA
Peking University
Phase 2 Terminated
NCT07326189 2026-01-16
PHAE-PHCC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase NA Not yet recruiting
NCT03104569 2025-12-26
Effect of 37â Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase NA Not yet recruiting
NCT06420349 2025-12-22
NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma
Mayo Clinic
Phase 1 Terminated
NCT05024513 2025-12-18
Biliary Drainage Plus HAIC in Locally Advanced pCCA
Peking University
Phase 2 Completed
NCT06850753 2025-08-21
SURE-LT
Oslo University Hospital
Phase NA Recruiting
NCT04993131 2025-07-31
TESLA II
Oslo University Hospital
Phase NA Recruiting
NCT03377179 2025-07-23
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma
RedHill Biopharma Limited
Phase 2 Completed
NCT06493734 2025-07-15
STRONG II
Erasmus Medical Center
Phase NA Recruiting
NCT07030140 2025-06-22
Phase II Study of Neoadjuvant Tislelizumab Plus Radiotherapy and GP Chemotherapy for Borderline/Unresectable Hilar Cholangiocarcinoma
Shandong Cancer Hospital and Institute
Phase 2 Not yet recruiting
NCT05239169 2025-05-01
Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer
Institut fĂźr Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2 Completed
NCT06923475 2025-04-11
NEODISCO
Amsterdam UMC, location VUmc
Phase 2/3 Not yet recruiting
NCT05551299 2025-03-27
CARP
University of Leipzig
Phase 4 Recruiting
NCT06717464 2024-12-05
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Active not recruiting
NCT05563870 2024-03-26
COMBO-RFA
Clinical Hospital Colentina
Phase NA Active not recruiting
NCT01825603 2023-12-28
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
University of Nebraska
Phase 1 Completed
NCT06175845 2023-12-19
ACTICCA-2
Universitätsklinikum Hamburg-Eppendorf
Phase NA Not yet recruiting
NCT06106750 2023-10-30
Endoscopic Scissors Cutting Nasobiliary Duct VS Bilateral Plastic Stent
First People's Hospital of Hangzhou
Phase NA Unknown
NCT05681949 2023-08-24
ADBoard
Charite University, Berlin, Germany
Phase NA Unknown
NCT05874934 2023-05-25
CHORDA-II-p
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Unknown
NCT04211168 2023-03-29
Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers
Peking Union Medical College Hospital
Phase 2 Unknown
NCT03353181 2022-08-25
ENBD
Changhai Hospital
Phase NA Withdrawn
NCT04611100 2022-03-23
Efficacy of Intraductal Radiofrequency Ablation in Combination With Metallic Biliary Stenting in Advanced Hilar Cholangiocarcinoma
Department of Medical Services Ministry of Public Health of Thailand
Phase NA Completed
NCT02232932 2021-11-03
TRANSPHIL
Assistance Publique - HĂ´pitaux de Paris
Phase NA Unknown
NCT04779788 2021-07-14
I-125 Seeds Loaded Stent Insertion for Inoperable Hilar Cholangiocarcinoma
Xuzhou Central Hospital
Phase NA Unknown
NCT03620292 2021-04-28
COUGAR
University Medical Center Groningen
Phase 1/2 Unknown
NCT03307538 2021-01-26
STRONG
Erasmus Medical Center
Phase NA Completed
NCT03383796 2020-10-08
Comparing Three Dimension Laparoscopic Versus Open Surgery for Perihiliar Cholangiocarcinoma
Tongji Hospital
Phase NA Unknown
NCT04386772 2020-06-17
Portal Vein Embolization Using Coils Plus TAGM vs Multiple Coils for Patients With Perihilar Cholangiocarcinoma or Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase NA Unknown
NCT02082522 2019-08-28
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Concordia Laboratories Inc.
Phase 3 Terminated
NCT02108145 2019-08-01
Percutaneous Bilateral Versus Unilateral Metal Stent for Hilar Cholangiocarcinoma
Air Force Military Medical University, China
Phase 2/3 Unknown
NCT02955771 2019-07-17
Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Phase 2 Terminated
NCT03104582 2019-07-11
Best Biliary Drainage Option in Advanced Klatskin Tumor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase NA Completed
NCT02958059 2019-01-16
Effectiveness of Prophylactic Antibiotics to Prevent Post Endoscopic Retrograde Cholangio Pancreatography Bacteremia in Biliary Obstruction Patient
Yonsei University
Phase NA Unknown
NCT03527875 2018-06-06
Process Optimization of Preoperative Biliary Drainage in Patients With Malignant Obstructive Jaundice
Shanghai Zhongshan Hospital
Phase NA Unknown
NCT02801500 2017-09-21
CTREG
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Unknown
NCT02042443 2017-09-12
S1310
National Cancer Institute (NCI)
Phase 2 Completed
NCT02166970 2017-03-01
Single Versus Multiple Deployment of Metallic Stents for Inoperable Malignant Hilar Biliary Obstruction
Soon Chun Hyang University
Phase NA Completed
NCT01093222 2015-06-30
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT02178280 2014-06-30
Safety Study of Liver Transplantation for Hilar Cholangiocarcinoma
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Unknown
NCT01549795 2012-07-18
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Azienda Ospedaliera di Padova
Phase NA Unknown
NCT01125865 2011-03-10
Uncovered Self-expandable Metal Stent Versus Double Layer Plastic Stent for Malignant Hilar Stricture
Soon Chun Hyang University
Phase 4 Unknown
NCT00746538 2008-09-04
Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Khon Kaen University
Phase 4 Unknown